作者：
Ghielmini,M. [1]
;
Vitolo,U. [2]
;
Kimby,E. [3]
;
Montoto,S. [4]
;
Walewski,J. [5]
;
Pfreundschuh,M. [6]
;
Federico,M. [7]
;
Hoskin,P. [8]
;
McNamara,C. [9]
;
Caligaris-Cappio,F. [10]
;
Stilgenbauer,S. [11]
;
Marcus,R. [12]
;
Trneny,M. [13]
;
Dreger,P. [14]
;
Montserrat,E. [15]
;
Dreyling,M. [16]
作者单位：
Institute of Hematology and Blood Transfusion, First Department of Medicine, Charles University
[1]
Department of Medicine V, University of Heidelberg, Heidelberg, Germany
[2]
Internal Medicine Clinic III, University Clinic Ulm, Ulm, Germany
[3]
Maria Slodowska-Curie Memorial Institute and Oncology Centre, Warszawa, Poland
[4]
Department of Hematology, Kings College Hospital, London, United Kingdom
[5]
Department of Onco-Hematology and Division of Molecular Oncology, San Raffaele Scientific Institute
[6]
Department of Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale San Giovanni
[7]
Department of Hematology, Mount Vernon Cancer Centre, Northwood, Italy
[8]
Medical Clinic III, Clinic of München University, Campus Grosshadern, München, Germany
[9]
Department of Hematology, The Royal Free Hospital, London, United Kingdom
[10]
Hematology Division Institute of Hematology and Oncology, IDIBAPS, University of Barcelona
[11]
Department of Oncology and Hematology, Hematology 2 Section, San Giovanni Battista Hospital, Torino
[12]
Center of Hematology, Karolinska University Hospital, Stockholm, Sweden
[13]
Departiment of Internal Medicine I, Saarlandes University, Homburg, Germany
[14]
Departiment of Oncology and Hematology, Universitá di Modena e Reggio Emilia, Policlinico, Modena
[15]
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University, London, United Kingdom
[16]
发布时间
2013-11-20
换一批
